Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4030693 | 1.00 | MGAM (0.33) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL2197713 | 0.79 | — | — | |
| SCHEMBL2197710 | 0.79 | — | — | |
| SCHEMBL4031968 | 0.71 | — | — | |
| SCHEMBL20156412 | 0.69 | — | — | |
| SCHEMBL4198457 | 0.68 | ALDH1A1 (0.31) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL4198456 | 0.68 | ALDH1A1 (0.31) | ALDH1A1LMNAHSD17B10 | |
| SCHEMBL4030700 | 0.68 | LMNA (0.35) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL22995132 | 0.67 | — | — | |
| SCHEMBL3226475 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7560593-B2 | Process for producing nitroisourea derivatives | MITSUI CHEMICALS, INC. (JP) | 2009-07-14 | — | — | US | disclosed |
| US-20090018363-A1 | PROCESS FOR PRODUCING NITROISOUREA DERIVATIVES | MITSUI CHEMICALS, INC (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1985610-A1 | IMPROVED METHOD FOR PRODUCING NITROISOUREA DERIVATIVE | Mitsui Chemicals, Inc. (JP) | 2008-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018363-A1 | PROCESS FOR PRODUCING NITROISOUREA DERIVATIVES | NOS2, NOS1, NIT2 | MGAM 134/4885GAA 212/4885SI 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.